The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose
Open accessAbstract
The effects of ingested and infused glucose upon circulating glucagon-like immunoreactivity (GLI) were compared in 14 triply catheterized conscious dogs. Within 60 min after the intraduodenal administration of 2 g/kg of glucose, the mean level of glucagon-like immunoreactivity in the vena caval plasma more than doubled, whereas after intravenous infusion of the same dose over a 90 min period no change in the mean vena caval level was observed; during glucose infusion mean glucagon-like immunoreactivity in the pancreatic venous effluent declined, suggesting that hyperglycemia suppresses rather than stimulates pancreatic glucagon secretion. To determine if the rise in glucagon-like immunoreactivity that occurs during glucose absorption was of pancreatic origin, the effect of pancreatectomy performed 1 hr after the intraduodenal administration of glucose was determined. Although circulating insulin disappeared after resection of the pancreas, the level of glucagon-like immunoreactivity continued to rise, establishing its extrapancreatic origin. In other experiments, measurements of Glucagon-like immunoreactivity in plasma obtained simultaneously from pancreaticoduodenal and mesenteric veins and from the vena cava revealed the increment after intraduodenal glucose loading to be greatest in the mesenteric vein in 8 of 12 experiments, favoring the gut as the likely source of the rise. To characterize gut glucagon-like immunoreactivity, acid-alcohol extracts of canine jejunum were compared with similar glucagon-containing extracts of canine pancreas with respect to certain physical and biological properties. On a G-25 Sephadex column the elution volume of the jejunal immunoreactivity was found to be smaller than that of glucagon, which suggested a molecular size at least twice that of pancreatic glucagon. Furthermore, the in vivo and in vitro biological activities of the eluates containing jejunal glucagon-like immunoreactivity appeared to differ from those of eluates containing pancreatic glucagon. The jejunal material lacked hyperglycemic activity when injected endoportally into dogs, was devoid of glycogenolytic activity in the isolated perfused rat liver, and did not increase hepatic 3',5' cyclic adenylate in the perfused liver; however, like glucagon it appeared to stimulate insulin release. It seems quite clear the material in intestinal extracts either is a different substance or a different form from that of true pancreatic glucagon, although it crossreacts in the radioimmunoassay with antibodies to glucagon. It is concluded, (a) that hyperglycemia does not stimulate and probably suppresses the secretion of pancreatic glucagon; (b) that during intestinal absorption of glucose, a rise in glucagon-like immunoreactivity occurs; (c) this immunoreactivity is derived from an extrapancreatic site, probably the gut; (d) that the glucagon-like immunoreactivity extractable from jejunum is not the same as pancreatic glucagon but is a larger molecule devoid of hyperglycemic and glycogenolytic activity, a cross-reactant in radioimmunoassay for glucagon; and (e) that the eluate in which jejunal immunoreactivity is contained can stimulate insulin release in conscious dogs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunoassay of endogenous plasma insulin in man
Yalow, R. S., & Berson, S. A. (1960) · Journal of Clinical Investigation · doi:10.1172/jci104130 · Cited by 3,041 · cited 1×
“Insulin was measured by the method of Yalow and Berson (9).”
MethodA RAPID PHOTOELECTRIC METHOD FOR THE DETERMINATION OF GLUCOSE IN BLOOD AND URINE
Hoffman, W. S. (1937) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)74360-3 · Cited by 1,286
Plasma Insulin Response to Oral and Intravenous Glucose Administration1
ELRICK, H., STIMMLER, L., HLAD, C. J., & ARAI, Y. (1964) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-24-10-1076 · Cited by 857
New Interpretation of Oral Glucose Tolerance
Mcintyre, N., Holdsworth, C. D., & Turner, D. S. (1964) · The Lancet · doi:10.1016/s0140-6736(64)90011-x · Cited by 738
Adenosine 3‘, 5‘-Monophosphate in Biological Materials
Butcher, R. W., Ho, R. J., Meng, H. C., & Sutherland, E. W. (1965) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)97092-4 · Cited by 596
Promotion of Insulin Secretion by Glucagon
Samols, E., Marri, G., & Marks, V. (1965) · The Lancet · doi:10.1016/s0140-6736(65)90761-0 · Cited by 521
THE EFFECTS OF TOTAL STARVATION UPON THE LEVELS OF CIRCULATING GLUCAGON AND INSULIN IN MAN*
Unger, R. H., Eisentraut, A. M., & Madison, L. L. (1963) · Journal of Clinical Investigation · doi:10.1172/jci104788 · Cited by 345
Self-citationUnger, R. H., Ketterer, H., Dupré, J., & Eisentraut, A. M. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105565 · Cited by 337
Self-citationGLUCAGON ANTIBODIES AND AN IMMUNOASSAY FOR GLUCAGON*
Unger, R. H., Eisentraut, A. M., McCall, M. S., & Madison, L. L. (1961) · Journal of Clinical Investigation · doi:10.1172/jci104357 · Cited by 285
Self-citationUnger, R. H., Eisentraut, A. M., McCall, M. S., & Madison, L. L. (1962) · Journal of Clinical Investigation · doi:10.1172/jci104525 · Cited by 278
Self-citationUse of Liver Adenyl Cyclase for Assay of Glucagon in Human Gastro-intestinal Tract and Pancreas1
Makman, M. H., & Sutherland, E. W. (1964) · Endocrinology · doi:10.1210/endo-75-1-127 · Cited by 157
STIMULATION OF GLUCAGON SECRETION BY ORAL GLUCOSE
Samols, E., Tyler, J., Marri, G., & Marks, V. (1965) · The Lancet · doi:10.1016/s0140-6736(65)92278-6 · Cited by 154
Effect of insulin on release of glucose and urea by isolated rat liver
Mortimore, G. E. (1963) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1963.204.4.699 · Cited by 154
EXTRACTABLE GLUCAGON OF THE HUMAN PANCREAS
Kenny, A. J. (1955) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-15-9-1089 · Cited by 138
Effect of glucagon on serum insulin, plasma glucose and free fatty acids in man.
Crockford, P., Porte, D., Wood, F. C., & Williams, R. H. (1966) · Metabolism: Clinical and Experimental · doi:10.1016/0026-0495(66)90032-1 · Cited by 124
Distribution of immunoassayable glucagon in gastrointestinal tissues
Unger, R. H., Ketterer, H., & Eisentraut, A. M. (1966) · Metabolism · doi:10.1016/0026-0495(66)90156-9 · Cited by 122
Self-citationIMMUNOCHEMICAL GLUCAGON IN HUMAN PANCREAS, GUT, AND PLASMA
Samols, E., Tyler, J., Megyesi, C., & Marks, V. (1966) · The Lancet · doi:10.1016/s0140-6736(66)92982-5 · Cited by 109
Lawrence, A. M. (1966) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.55.2.316 · Cited by 106
Plasma Insulin Activity after Glucose: An Index of Insulogenic Reserve in Normal and Diabetic Man
Seltzer, H. S., & Smith, W. L. (1959) · Diabetes · doi:10.2337/diab.8.6.417 · Cited by 87
Sokal, J. E. (1966) · The American Journal of Medicine · doi:10.1016/0002-9343(66)90079-9 · Cited by 81
Effect upon Insulin Secretion of Physiologic Doses of Glucagon Administered via the Portal Vein
Ketterer, H., Eisentraut, A. M., & Unger, R. H. (1967) · Diabetes · doi:10.2337/diab.16.5.283 · Cited by 68
Self-citationStudies of the Physiologic Role of Glucagon
Unger, R. H., & Eisentraut, A. M. (1964) · Diabetes · doi:10.2337/diab.13.6.563 · Cited by 65
Self-citationFoà, P. P., Weinstein, H. R., & Smith, J. A. (1949) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1949.157.2.197 · Cited by 61
NEW INTERPRETATION OF ORAL GLUCOSE TOLERANCE
Nordio, S., Lamedica, G., Vignolo, L., & Berio, A. (1964) · The Lancet · doi:10.1016/s0140-6736(64)91135-3 · Cited by 41
Glucagon Antibodies and an Immunoassay for Glucagon
(1961) · Journal of Clinical Investigation · doi:10.1172/jci104357c1 · Cited by 19
Cited by
Biology of Incretins: GLP-1 and GIP
Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Glucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868
“Notably, the circulating glucagonlike material was also detected in 1967 by Samols and Marks in pancreatectomized humans [21] and in the following year by Roger Unger and Isabel Valverde in dogs [27].”
BackgroundInfluentialPolypeptide with Broad Biological Activity: Isolation from Small Intestine
Said, S. I., & Mutt, V. (1970) · Science · doi:10.1126/science.169.3951.1217 · Cited by 1,596
Kieffer, T. J., & Francis Habener, J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0385 · Cited by 1,062
Metadata
- Authors
- Unger, R. H., Ohneda, A., Valverde, I., Eisentraut, A. M., & Exton, J.
- Venue
- Journal of Clinical Investigation
- Published
- 1968-01-01
- Volume
- 47
- Issue
- 1
- Pages
- 48-65
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2153660163
- Cited by
- 296
- References
- 25
- FWCI
- 111.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.